Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Angiotech starts EU trial for broader indication of Vascular Wrap

This article was originally published in Clinica

Executive Summary

Pressing on with efforts to expand the potential market for its Vascular Wrap - a paclitaxel-eluting mesh - Angiotech Pharmaceuticals has begun a European trial of the device in dialysis patients with end-stage renal disease. The technology is currently awaiting EU approval for use in advanced peripheral arterial disease of the lower limbs. The 198-patient EU trial is assessing its use after surgical implantation with an ePTFE vascular graft in the upper extremity for haemodialysis vascular access; a control group of patients will receive the standard of care - an ePTFE vascular graft alone. A pivotal trial in the US is also underway for assessing the AV access indication. The Vancouver, Canada-based firm expects to use the EU trial data along with the US trial results to support a CE-mark submission.

You may also be interested in...



Real World Data Failed To Impress Kaftrio’s European Reviewers

The European public assessment report for Kaftrio shows that EU regulators had concerns about whether Vertex’s triple drug combination for cystic fibrosis represented a new treatment paradigm.

Swissmedic Clears Up Confusion Over Validity Of GMP Certificates

Swissmedic says its good manufacturing practice certificates remain valid for longer than companies might assume. Separately, it is giving companies more time to conduct nitrosamine-related risk evaluations.

People On The Move: Appointments At Stada, PGEU, And UK Health Claims Committee

Stada has appointed a head of digital communications; PGEU elects new chair and vice-chair; and the new UK health claims committee unveils its first members.

Topics

UsernamePublicRestriction

Register

OM011382

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel